Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Hypertension (High Blood Pressure)
Trial Information
This study will evaluate the efficacy and safety of nebivolol in Hispanic subjects with hypertension.
Subjects who are of Hispanic origin and have hypertension (high blood pressure) are being asked to participate in this study to study the effects of a new drug called nebivolol. If you are already taking medication to treat your blood pressure, you will be asked to stop taking all the blood pressure medication that you are taking. If you are not taking medication to treat your blood pressure, you will receive counseling on changes you should make to your diet and exercise program that may help to lower your blood pressure. All subjects will take a placebo (inactive sugar pill) or nebivolol at some point during the study.
Subjects who have hypertension (whether or not they are currently being treated with up to 2 medications) are eligible to participate. Participation in this study will last approximately 4 months and will involve up to 12 visits to the study center.
Ana Melendez, Study Coordinator
National Research Institute
2010 Wilshire Blvd., Suite 302
Los Angeles, CA 90057
Phone: 213-483-1800
Fax: 213-483-1494
EMail: Aname@sbcglobal.net
View Google Map
Research Center Information: National Research Institute
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
